Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor

Journal of Hepatology

Volumn 41, Issue 1, 2004, Pages 104-111

  Fujii, Tsutomu ^a   Koshikawa, Katsumi ^a   Nomoto, Shuji ^a   Okochi, Osamu ^a   Kaneko, Tetsuya ^a   Inoue, Soichiro ^a   Yatabe, Yasushi ^b   Takeda, Shin ^a   Nakao, Akimasa ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Focal adhesion kinase; Hepatocellular carcinoma; Prognostic factor; Quantitative RT PCR

Indexed keywords

FOCAL ADHESION KINASE; MESSENGER RNA; PROTEIN TYROSINE KINASE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 3442890219     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.03.029     Document Type: Article

References (32)

1. Arii S., Okamoto E., Imamura M. Registries in Japan: current status of hepatocellular carcinoma in Japan. Liver Cancer Study Group of Japan. Semin Surg Oncol. 12:1996;204-211
2. Mise K., Tashiro S., Yogita S., Wada D., Harada M., Fukuda Y., et al. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis. Clin Cancer Res. 4:1998;1475-1482
3. Arteaga C.L., Johnson M.D., Todderud G., Coffey R.J., Carpenter G., Page D.L. Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc Natl Acad Sci USA. 88:1991;10435-10439
4. Irby R.B., Mao W., Coppola D., Kang J., Loubeau J.M., Trudeau W., et al. Activating SRC mutation in a subset of advanced human colon cancers. Nat Genet. 21:1999;187-190
5. Schaller M.D., Borgman C.A., Cobb B.S., Vines R.R., Reynolds A.B., Parsons J.T. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA. 89:1992;5192-5196
6. Lipfert L., Haimovich B., Schaller M.D., Cobb B.S., Parsons J.T., Brugge J.S. Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets. J Cell Biol. 119:1992;905-912
7. Schlaepfer D.D., Hanks S.K., Hunter T., van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature. 372:1994;786-791
8. Cary L.A., Chang J.F., Guan J.L. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J Cell Sci. 109:1996;1787-1794
9. Parsons J.T., Martin K.H., Slack J.K., Taylor J.M., Weed S.A. Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene. 19:2000;5606-5613
10. Frisch S.M., Vuori K., Ruoslahti E., Chan-Hui P.Y. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol. 134:1996;793-799
11. Hungerford J.E., Compton M.T., Matter M.L., Hoffstrom B.G., Otey C.A. Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. J Cell Biol. 135:1996;1383-1390
12. Burridge K., Turner C.E., Romer L.H. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J Cell Biol. 119:1992;893-903
13. Guan J.L., Trevithick J.E., Hynes R.O. Fibronectin/integrin interaction induces tyrosine phosphorylation of a 120-kDa protein. Cell Regul. 2:1991;951-964
14. Schaller M.D., Otey C.A., Hildebrand J.D., Parsons J.T. Focal adhesion kinase and paxillin bind to peptides mimicking beta integrin cytoplasmic domains. J Cell Biol. 130:1995;1181-1187
15. Romer L.H., McLean N., Turner C.E., Burridge K. Tyrosine kinase activity, cytoskeletal organization, and motility in human vascular endothelial cells. Mol Biol Cell. 5:1994;349-361
16. Weiner T.M., Liu E.T., Craven R.J., Cance W.G. Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors. Ann Surg Oncol. 1:1994;18-27
17. Owens L.V., Xu L., Craven R.J., Dent G.A., Weiner T.M., Kornberg L., et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res. 55:1995;2752-2755
18. Cance W.G., Harris J.E., Iacocca M.V., Roche E., Yang X., Chang J., et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res. 6:2000;2417-2423
19. Owens L.V., Xu L., Dent G.A., Yang X., Sturge G.C., Craven R.J., et al. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann Surg Oncol. 3:1996;100-105
20. Tremblay L., Hauck W., Aprikian A.G., Begin L.R., Chapdelaine A., Chevalier S. Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma. Int J Cancer. 68:1996;164-171
21. Judson P.L., He X., Cance W.G., Van Le L. Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma. Cancer. 86:1999;1551-1556
22. Kornberg L.J. Focal adhesion kinase expression in oral cancers. Head Neck. 20:1998;634-639
23. Miyazaki T., Kato H., Nakajima M., Sohda M., Fukai Y., Masuda N., et al. FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer. 89:2003;140-145
24. McCormack S.J., Brazinski S.E., Moore J.L. Jr, Werness B.A., Goldstein D.J. Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18. Oncogene. 15:1997;265-274
25. Miyasaka Y., Enomoto N., Nagayama K., Izumi N., Marumo F., Watanabe M., et al. Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization. Br J Cancer. 85:2001;228-234
26. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. 4th ed :2000;Kanehara, Tokyo
27. Lau H., Fan S.T., Ng I.O., Wong J. Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients. Cancer. 83:1998;2302-2311
28. Weiner T.M., Liu E.T., Craven R.J., Cance W.G. Expression of focal adhesion kinase gene and invasive cancer. Lancet. 342:1993;1024-1025
29. Lark A.L., Livasy C.A., Calvo B., Caskey L., Moore D.T., Yang X., et al. Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. Clin Cancer Res. 9:2003;215-222
30. Ilic D., Almeida E.A., Schlaepfer D.D., Dazin P., Aizawa S., Damsky C.H. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J Cell Biol. 143:1998;547-560
31. Chen H.C., Appeddu P.A., Isoda H., Guan J.L. Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase. J Biol Chem. 271:1996;26329-26334
32. Xu L.H., Yang X., Bradham C.A., Brenner D.A., Baldwin A.S. Jr, Craven R.J., et al. The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. Involvement of death receptor-related signaling pathways. J Biol Chem. 275:2000;30597-30604